Progressiverx Pharma Operations Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 27-06-2024
- Paid Up Capital ₹ 0.10 M
as on 27-06-2024
- Company Age 16 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 2.50 M
as on 27-06-2024
- Revenue 4.23%
(FY 2022)
- Profit -8.47%
(FY 2022)
- Ebitda -37.70%
(FY 2022)
- Net Worth 5.14%
(FY 2022)
- Total Assets -16.22%
(FY 2022)
About Progressiverx Pharma Operations
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹2.50 M.
Edukula Umadevi and Hayden Hamilton serve as directors at the Company.
- CIN/LLPIN
U51109KA2008PTC047849
- Company No.
047849
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
25 Sep 2008
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Progressiverx Pharma Operations?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Edukula Umadevi  | Director | 25-Sep-2008 | Current |
Hayden Hamilton  | Director | 25-Sep-2008 | Current |
Financial Performance of Progressiverx Pharma Operations.
Progressiverx Pharma Operations Private Limited, for the financial year ended 2022, experienced modest growth in revenue, with a 4.23% increase. The company also saw a slight decrease in profitability, with a 8.47% decrease in profit. The company's net worth moved up by a moderate rise of 5.14%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Progressiverx Pharma Operations?
In 2020, Progressiverx Pharma Operations had a promoter holding of 90.00% and a public holding of 10.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Greenprint Technologies Private LimitedActive 16 years 10 monthsEdukula Umadevi and Hayden Hamilton are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 27 Nov 2021 | ₹2.50 M | Open |
How Many Employees Work at Progressiverx Pharma Operations?
Unlock and access historical data on people associated with Progressiverx Pharma Operations, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Progressiverx Pharma Operations, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Progressiverx Pharma Operations's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
